Max India Limited (MAXIND) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Max India Limited stock ₹126, price ₹145, that is 13.1% below the price, quality 35 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Max India Limited
MAXIND · NSEExpensive (fair value 13% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range ₹67.85 – ₹329.60 · fair‑value band ₹94.61 – ₹157.69 · the ₹145.23 price screens above the ₹126.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Max India is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Max India Limited provides services related to senior living communities in India. It operates through four segments: Business Investments, Senior Living, Assisted Care, and Others. The company engages in the treasury investments and investment property businesses.
Show moreShow less
It also offers senior living services. In addition, the company caters to the seniors by providing care at home services and care homes facilities, as well as offers Antara AGEasy, which is a new-age holistic direct to consumer platform that helps seniors manage common chronic conditions.
Further, it offers daily living/specialized care/memory care services for seniors; and management and consultancy and shared services, as well as MedCare products.
Additionally, the company engages in the learning and development activities; construction and leasing of senior living communities; and management of investments activities. The company was formerly known as Advaita Allied Health Services Limited.
Max India Limited was incorporated in 2019 and is based in Gurugram, India.
Stock analysis
Max India Limited (MAXIND) currently trades at ₹145.23, while our estimate is ₹126.15, 13% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₹94.61 (bear) to ₹157.69 (bull), the price of ₹145.23 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Max India Limited reported revenue of ₹1.9B in FY2026 versus ₹1.7B in FY2022, a compound +3.0%/yr. Reported net income was −₹1.2B in FY2026.
Key figures
Market cap ₹8.2B (≈ $87.1M) Micro · P/S ratio 3.47 · EPS (TTM) ₹−25.27 · Net margin −55.4% · Return on equity −31.8% · Return on assets (EBIT) −9.3% (5-year average) · Operating margin −19.7% · Revenue (TTM) ₹2.4B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (medium confidence).
What moves the price
The share trades about 29% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −13%, MAXIND screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
MAXIND screens overvalued: fair value 13% below the price. Compare with HCA Healthcare, Inc →
Compare Max India Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 248 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Revenue growth by industry
- PEG ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $21.86 | $45.73 | +109% | vs MAXIND |
| DaVita Inc DVA | $174.22 | $218.90 | +26% | vs MAXIND |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs MAXIND |
| HCA Healthcare, Inc HCA | $511.78 | $547.34 | +7% | vs MAXIND |
| Tenet Healthcare Corporation THC | $291.54 | $279.20 | −4% | vs MAXIND |
| The Ensign Group ENSG | $188.23 | $140.09 | −26% | vs MAXIND |
| Encompass Health Corporation EHC | $142.11 | $94.81 | −33% | vs MAXIND |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs MAXIND |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs MAXIND |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs MAXIND |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Max India Limited (MAXIND) overvalued or undervalued?
What is the fair value of MAXIND?
What is the quality score of MAXIND?
What is the price target for Max India Limited (MAXIND)?
What is the Max India Limited stock forecast for 2026?
What is the revenue of Max India Limited (MAXIND)?
What is the intrinsic value of Max India Limited (MAXIND)?
Is Max India Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MAXIND?
How much is Max India Limited worth?
What do the bullish and bearish scenarios say about MAXIND?
How solid is the balance sheet of Max India Limited (MAXIND)?
How far is MAXIND from its 52-week high?
Which stocks are comparable to Max India Limited?
Is Max India Limited stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Max India Limited (MAXIND)?
What should I pay attention to with Max India Limited right now?
Key figures of Max India Limited
How large is the market capitalisation of Max India Limited (MAXIND)?
What is the P/S ratio of Max India Limited (MAXIND)?
What are the earnings per share of Max India Limited (MAXIND)?
What is the net margin of Max India Limited (MAXIND)?
What is the return on equity of Max India Limited (MAXIND)?
What is the EBIT return on assets of Max India Limited (MAXIND)?
What is the operating margin of Max India Limited (MAXIND)?
How fast is revenue growing at Max India Limited (MAXIND)?
How much free cash flow does Max India Limited (MAXIND) generate?
How much net debt does Max India Limited (MAXIND) carry?
Watch Max India Limited in the live analysis
One click puts Max India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.